WX-554

DRUG2 trials

Sponsors

Heidelberg Pharma AG

Conditions

Advanced Solid Tumours

Phase 1

Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours

TerminatedNCT01581060

Heidelberg Pharma AGAdvanced Solid Tumours

Start: 2012-03-31End: 2014-04-30Updated: 2014-05-16

Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours

TerminatedNCT01859351

Heidelberg Pharma AGAdvanced Solid Tumours

Start: 2013-07-31End: 2014-04-30Updated: 2014-05-16